Sarnia, Canada
Sarnia, Canada

Time filter

Source Type

Patent
LANXESS Inc. and University of Western Ontario | Date: 2016-06-08

A polymer-drug conjugate, which can be used in medical applications such as stents, has at least one active agent conjugated through a carboxylic acid moiety to a copolymer derived from at least one isoolefin monomer and at least one copolymerizable monomer, where the copolymerizable monomer is at least one multiolefin monomer, a -pinene monomer or a mixture thereof. Such conjugates show improved adhesion to stainless steel and a substantial decrease in burst release of paclitaxel form a drug eluting stent (DES).


A process for producing a copolymer involves contacting at least one isoolefin monomer with at least one multiolefin and/or -pinene monomer in the presence of at least one Lewis acid and at least one initiator in a diluent. The diluent contains a hydrofluorinated olefin (HFO) comprising a tetrafluorinated propene. Copolymers produced by a process of the present invention have a cyclic oligomer content lower than comparable polymers produced in a butyl rubber slurry process using 1,1,1,2-tetrafluoroethane and/or methyl chloride as a diluent as well as a more favourable ratio of C21/C13. Hydrofluorinated olefins used in the present invention are better diluents for butyl slurry cationic polymerization than saturated hydrofluorocarbons


Patent
LANXESS Inc. | Date: 2016-05-04

An adhesive composition that contains a tackifier, a butyl rubber ionomer and a plasticizer. The hot melt adhesive compositions may exhibit one or more of improved creep resistance and improved adhesion.


Patent
LANXESS Inc. | Date: 2016-02-24

A polymeric compound involves a blend of 50 wt% or greater of a thermoplastic having an average melting point (T_(m)) of less than 200C and less than 50 wt% of a butyl rubber ionomer dispersed in a matrix of the thermoplastic, weights based on total weight of the thermoplastic and butyl rubber ionomer. Such blends may exhibit improved physical properties compared to unblended thermoplastic, particularly ultimate elongation and/or damping. The polymeric compounds are useful for forming a variety of articles of manufacture.


Patent
LANXESS Inc. | Date: 2015-11-04

A copolymer has low levels of cyclic oligomeric compounds, which are undesirable impurities in certain applications. The cyclic oligomeric compounds are provided in an advantageously low ratio of C21/C13 oligomers. The C13 oligomers are extractable using steam to further reduce the total amount of cyclic oligomers. A process for producing the copolymer having low levels of cyclic oligomers involves contacting at least one isoolefin monomer with at least one multiolefin and/or -pinene monomer in the presence of at least one Lewis acid and at least one initiator in a diluent. The diluent contains a hydrofluorinated olefin (HFO) comprising at least three carbon atoms and at least three fluorine atoms. Hydrofluorinated olefins used in the present invention are better diluents for butyl slurry cationic polymerization than saturated hydrofluorocarbons.


Patent
LANXESS Inc. | Date: 2015-11-04

A copolymer has low levels of isoprenoid (short chain branching) structures. A process for producing the copolymer having low isoprenoid content involves contacting at least one isoolefin monomer with at least one multiolefin and/or -pinene monomer in the presence of at least one Lewis acid and at least one initiator in a diluent. The diluent may contain a hydrofluorinated olefin (HFO) comprising at least three carbon atoms and at least three fluorine atoms. Hydrofluorinated olefins used in the present invention are better diluents for butyl slurry cationic polymerization than saturated hydrofluorocarbons. Blends of saturated hydrofluorocarbons (e.g. 1,1,1,2-tetrafluoroethane) with an inert solvent (e.g. methyl chloride) may also be used as diluents.


The present invention is directed to the functionalization of butyl rubber ionomer and optionally the grafting of polyamide to halobutyl rubber ionomers. Specifically, disclosed are methods and products resulting therefrom for creating functionalized ionomers and grafting polyamide to halobutyl ionomers via reactive extrusion. The process comprises reacting a halobutyl polymer with at least one nitrogen and/or phosphorous based nucleophile to provide a halobutyl ionomer comprising conjugated diene units; grafting of an amine-reactive dienophile to said ionomer to form a functionalized ionomer; and optionally blending the resulting functionalized ionomer with polyamide.


Patent
LANXESS Inc. | Date: 2016-09-28

A halogenated polyisoolefin copolymer is composed of at least one isoolefin monomer, at least one multiolefin monomer, a halogen content of 0.05-2.5 mol%, and a halogenated oligomer content of less than 65% of total oligomer content in the halogenated polyisoolefin copolymer. The copolymer has low halogen content and significantly reduced levels of halogenated oligomers. The copolymer is especially useful in the pharmaceutical and food industries, for example as pharmaceutical and food product seals and closures.


Patent
LANXESS Inc. | Date: 2015-11-04

A copolymer has high levels of multolefin incorporation. A process for producing the copolymer having high levels of multiolefin incorporation involves contacting at least one isoolefin monomer with at least one multiolefin and/or -pinene monomer in the presence of at least one Lewis acid and at least one initiator in a diluent. The diluent contains a hydrofluorinated olefin (HFO) comprising at least three carbon atoms and at least three fluorine atoms. Hydrofluorinated olefins used in the present invention are better diluents for butyl slurry cationic polymerization than saturated hydrofluorocarbons.


Patent
LANXESS Inc. | Date: 2016-01-13

A method of separating a polyisoolefin elastomer from non-polymeric components in an organic solvent involves ultrafiltration of a solution of the polyisoolefin elastomer and non-polymeric components in an organic solvent through a semipermeable membrane to substantially retain the polyisoolefin elastomer in a retentate and provide the non-polymeric components in a permeate. Advantageously, stabilizers for the polyisoolefin elastomer are retained in the retentate along with the polyisoolefin elastomer, permeate flux through the membrane is higher as concentration of the polyisoolefin elastomer in the solution increases up to a concentration limit, the separated polyisoolefin elastomer in the retentate has a molecular weight that can be substantially unchanged even when ultrafiltration is conducted at elevated temperature and the amount of polyisoolefin elastomer in the permeate is unmeasurable providing an oligomer-rich permeate uncontaminated by polyisoolefin elastomer.

Loading LANXESS Inc. collaborators
Loading LANXESS Inc. collaborators